NuVasive Reports Third Quarter 2015 Financial Results

Go back to NuVasive Reports Third Quarter 2015 Financial Results

Leerink Partners Cuts Price target on NuVasive (NUVA) Following 3Q Beat

October 28, 2015 8:11 AM EDT

Leerink Partners maintained an Outperform rating on NuVasive (NASDAQ: NUVA), and cut the price target to $60.00 (from $65.00), following the company's 3Q15 earnings results. Sales of ~$201M matched consensus, as EPS beat consensus by $0.08. Revenue guidance of $810M was reiterated.

Analyst Richard Newitter... More

NuVasive (NUVA) Tops Q3 EPS by 8c, Offers Guidance

October 27, 2015 4:12 PM EDT

NuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.35, $0.08 better than the analyst estimate of $0.27. Revenue for the quarter came in at $200.5 million versus the consensus estimate of $200.2 million.

Annual Guidance for 2015

The Company provided the following updated projections to its full year 2015 guidance:

Revenue of... More